Efficacy of intravenous levetiracetam in neonatal seizures: NEOLEV2–a multicenter, randomized, blinded, controlled phase IIb trial of the optimal dose, efficacy, and safety of levetiracetam compared with phenobarbital in the first-line treatment of neonatal seizures - Haas, R H; Nespeca, M; Rismanchi, N (2019)
. Accessed July 19, 2019